News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
60 Results
Type
Article (5)
Press Release (55)
Section
Business (6)
Deals (3)
Drug Development (1)
FDA (1)
News (15)
Policy (4)
Tag
Alliances (5)
Approvals (1)
Cancer (1)
Data (1)
Earnings (1)
Events (2)
FDA (1)
Healthcare (5)
IPO (3)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
People (1)
Preclinical (1)
Prostate cancer (1)
Regulatory (4)
Date
Last 365 days (3)
2025 (3)
2022 (5)
2021 (1)
2020 (1)
2019 (6)
2017 (10)
2016 (6)
2015 (16)
2014 (9)
2013 (2)
2011 (1)
Location
Asia (35)
Australia (47)
Europe (4)
Pennsylvania (2)
United States (2)
60 Results for "orthocell".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Orthocell Receives US Market Clearance
Australian-based regenerative medicine company, Orthocell Ltd, has achieved US 510k clearance to market and supply its collagen medical device Striate+TM in the US dental bone and tissue regeneration market.
January 15, 2021
·
2 min read
Press Releases
Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
September 16, 2025
·
3 min read
Deals
Orthocell announces successful capital raising
Regenerative medicine company Orthocell Limited is pleased to announce that it has received firm commitments for a A$10.6m placement (“Placement”) from professional and sophisticated investors, including existing shareholders providing $10m net of expenses.
May 31, 2019
·
2 min read
Orthocell Granted European Tendon Regeneration Patent
Regenerative medicine company Orthocell is pleased to announce it has been granted a key European Patent.
December 15, 2017
·
3 min read
Orthocell Granted Celgro Patent Protection In Canada
Regenerative medicine company Orthocell Limited is pleased to announce it has been granted a Canadian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications.
October 16, 2017
·
3 min read
Press Releases
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
June 23, 2025
·
19 min read
FDA
Orthocell Receives CE Mark for CelGro
CelGro, for a range of dental bone and soft tissue regeneration procedures, can now be marketed and sold within the European Union (EU).
November 8, 2017
·
4 min read
Business
Orthocell Appoints Surgical Specialties As Exclusive Distributor
October 11, 2017
·
2 min read
Orthocell Receives New Patent For Celgro Platform Technology
September 21, 2017
·
2 min read
Orthocell Commences Treatment of its 1,000th Patient
This marks a significant milestone in the Company’s history as it continues to clinically validate its market leading regenerative medicine technologies and drive entry into the US, the world’s largest healthcare market.
December 7, 2017
·
4 min read
1 of 6
Next
